SYMPTOMATIC IMPROVEMENT WITH MITRACLIP THERAPY FOR PROHIBITIVELY HIGH-RISK DMR PATIENTS
2015
Percutaneous
mitral valve repairusing the transcatheter
MitraClipdevice is a novel therapy recently FDA approved for patients with severe degenerative mitral regurgitation (DMR) who are at prohibitive risk for surgery. We herein report the results of an ongoing
single-centerpost-market series in
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI